SCHEMBL7584087

SCHEMBL7584087

O=c1[nH]c2nc(O)nnc2cc1-c1c(Cl)cccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GUSB P08236 1/20 0.39
▸ DAO P14920 2/20 0.38
▸ PDE3B Q13370 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ YES1 P07947 2/20 0.38
▸ EPHB4 P54760 2/20 0.38
▸ SRC P12931 5/20 0.37
▸ FGFR1 P11362 4/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ GRIA1 P42261 1/20 0.35
▸ CACNG8 Q8WXS5 1/20 0.35
▸ DGAT1 O75907 2/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ PDGFRB P09619 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ MAPK14 Q16539 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ MDM2 Q00987 1/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ WEE1 P30291 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7585252 0.81 FGFR1 (0.38) GUSBPDE3BPDE3AYES1EPHB4
SCHEMBL7592096 0.71 FGFR1 (0.54) SRCFGFR1ABL1PDGFRBPDGFRA
SCHEMBL16986359 0.68 DHFR (0.41) GUSBPDE3BPDE3ASRCFGFR1
SCHEMBL5619944 0.68 SRC (0.56) SRCFGFR1ABL1PDGFRBPDGFRA
SCHEMBL5659394 0.65 FGFR1 (0.45) YES1EPHB4SRCFGFR1ABL1
SCHEMBL29536840 0.65 FGFR1 (0.45) YES1EPHB4SRCFGFR1ABL1
SCHEMBL6643371 0.65 FGFR1 (0.43) GUSBDAOPDE3BPDE3ASRC
SCHEMBL14161489 0.64 RIPK2 (0.46) SRCFGFR1ABL1PDGFRBPDGFRA
SCHEMBL16986331 0.63 FGFR1 (0.61) SRCFGFR1ABL1PDGFRBPDGFRA
SCHEMBL6639245 0.63 FGFR1 (0.53) SRCFGFR1GRIA1CACNG8ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076396-A2 COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES SMITHKLINE BEECHAM CORPORATION (US) 2002-10-03 — — WO disclosed
Send feedback